News Releases

Date	Title
05/12/22	Optinose Reports First Quarter 2022 Financial Results and Operational Updates
05/05/22	Optinose Announces Reporting Date for First Quarter 2022 Financial Results
04/26/22	Optinose Announces Appointment of R. John Fletcher to the Board
04/08/22	Optinose to Present at the Needham Virtual Healthcare Conference
03/08/22	Optinose Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
03/07/22	Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
03/04/22	Optinose Announces Reporting Date for Fourth Quarter 2021 Financial Results

Keyword Search